During the past decade, Diagnostics Research Group conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 28 clinical trials were completed, i.e. on average, 75.7% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 21 clinical trials were completed. i.e. 91.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Diagnostics Research Group" #1 sponsor was "Pfizer" with 15 trials, followed by "Boehringer Ingelheim" with 7 trials sponsored, "Merck Sharp & Dohme LLC" with 4 trials sponsored, "Actelion" with 2 trials sponsored and "Altimmune, Inc." with 2 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Diagnostics Research Group" #1 collaborator was "Allergan Sales, LLC" with 2 trials as a collaborator, "Allied Research International" with 1 trials as a collaborator, "Institut de Recherches Internationales Servier" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Diagnostics Research Group" are "Osteoarthritis" (7 trials), "Chronic Obstructive Pulmonary Disease" (4 trials), "Seasonal Allergic Rhinitis" (4 trials), "Arthritis" (3 trials) and "Chronic Cough" (3 trials). Many other conditions were trialed in "Diagnostics Research Group" in a lesser frequency.

Most popular intervention types in "Diagnostics Research Group" are "Drug" (41 trials), "Biological" (21 trials) and "Other" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (33 trials), "tanezumab" (4 trials), "Nintedanib" (3 trials), "placebo" (3 trials) and "ALT-801" (2 trials). Other intervention names were less common.

The vast majority of trials in "Diagnostics Research Group" are 57 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Diagnostics Research Group". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 43 completed trials in Diagnostics Research Group, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Diagnostics Research Group, 5 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".